News & Blog

News & Blog

| Mar 19 2024

A Study of Vatiquinone for the Treatment of Participants with Friedreich’s Ataxia

News | May 23 2023

PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial

Industry News
News | Nov 30 2020

PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia

Industry News
News | Mar 17 2014

FDA Awards Fast Track Status to Edison Pharmaceuticals’ EPI-743 for Friedreich’s Ataxia

Industry News
News | Feb 4 2014

FDA Grants Edison Pharmaceuticals’ EPI-743 Orphan Status for Friedreich’s Ataxia

Industry News